Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004671766 | SCV005161885 | uncertain significance | Inborn genetic diseases | 2024-05-10 | criteria provided, single submitter | clinical testing | The c.1176G>T (p.E392D) alteration is located in exon 11 (coding exon 10) of the RDX gene. This alteration results from a G to T substitution at nucleotide position 1176, causing the glutamic acid (E) at amino acid position 392 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |